Detalhe da pesquisa
1.
Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study.
Acta Oncol
; 61(11): 1339-1346, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239950
2.
Implementation of a molecular tumor board at a regional level to improve access to targeted therapy.
Int J Clin Oncol
; 25(7): 1234-1241, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32215806
3.
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
Lancet Oncol
; 20(2): 239-253, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30660609
4.
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Br J Cancer
; 120(4): 387-397, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30739911
5.
Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France.
Oncology
; 95(6): 337-343, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30278447
6.
Effect of Continuous versus Intermittent Subglottic Suctioning on Tracheal Mucosa by the Mallinckrodt TaperGuard Evac Oral Tracheal Tube in Intensive Care Unit Ventilated Patients: A Prospective Randomized Study.
Indian J Crit Care Med
; 22(1): 1-4, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29422724
7.
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Lancet
; 387(10026): 1405-1414, 2016 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719230
8.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Lancet Oncol
; 13(3): 239-46, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22285168
9.
Reaching multidisciplinary consensus on the management of non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer.
Lung Cancer
; 177: 21-28, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682142
10.
Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).
Lung Cancer
; 178: 191-197, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868180
11.
Real-life second-line epirubicin-paclitaxel regimen as treatment of relapsed small-cell lung cancer: EpiTax study.
Cancer Med
; 12(3): 2658-2665, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36000584
12.
Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study.
J Geriatr Oncol
; : 101506, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211514
13.
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study.
Target Oncol
; 18(4): 585-591, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310660
14.
Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29).
Transl Lung Cancer Res
; 12(2): 266-276, 2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895931
15.
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Target Oncol
; 18(6): 905-914, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966566
16.
Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.
JAMA
; 307(9): 948-55, 2012 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22396517
17.
[Semantic analysis of online conversations on lung cancer: The WE-Lung research]. / Analyse sémantique de conversations sur le web portant sur le cancer du poumon : étude Web Ethnography-Lung.
Bull Cancer
; 109(7-8): 805-816, 2022.
Artigo
em Francês
| MEDLINE | ID: mdl-35599172
18.
Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.
JCO Clin Cancer Inform
; 6: e2100108, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35113656
19.
Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF).
Cancers (Basel)
; 14(3)2022 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35159036
20.
Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.
Lancet Reg Health Eur
; 22: 100492, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108315